Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAAA.L Regulatory News (AAA)

  • There is currently no data for AAA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement by MESH and AAQUA to acquire Sentiance

15 Feb 2021 07:00

RNS Number : 0020P
All Active Asset Capital Limited
15 February 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014 ("MAR") (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018).

 

15 February 2021

 

All Active Asset Capital Limited

('AAA' or the 'Company')

Agreement by MESH and AAQUA to acquire Sentiance

 

AAA has been informed by MESH Holdings plc ('MESH') and AAQUA BV ('AAQUA') that they have entered into a definitive sale and purchase agreement ('SPA') to acquire Sentiance NV ('Sentiance'). Upon completion, MESH will increase its holding in Sentiance to 80% on a fully diluted basis, with the remaining 20% on a fully diluted basis owned by AAQUA.

According to the SPA, it is expected that the Sentiance acquisition will complete by 10 March 2021. Once the acquisition has completed, a further statement is expected to be made by MESH and AAQUA.

AAA has an interest in MESH via a €3.65 million Convertible Loan Note that can be converted, at the sole discretion of AAA, into ordinary MESH shares at 40 pence per share. In addition, AAA has an option agreement with AAQUA, which, under certain conditions, allows AAA to subscribe for up to 125,000 new AAQUA ordinary shares at €1,000 per share, being a total of €125 million if fully exercised. Further details of the terms of AAA's Convertible Loan Note with MESH and option agreement with AAQUA can be found in the Company's announcements of 17 and 18 December 2020 respectively.

Sentiance is an emerging and leading organisation within behavioural, ethical artificial intelligence and machine learning with its 'Motion Intelligence' and 'Behavioural Change Platform' technologies. Sentiance has partnerships, extended partnerships and contracts with well-known international businesses, including several within the Fortune 500.

AAQUA's mission is to reimagine the communities of passion and empower them into self-perpetuating economies across the globe. The distinct AAQUA proposition is delivered around authenticity, inclusiveness and creativity, and is aimed at ensuring digital engagement can be conducted in a genuinely trusted environment with real human interaction.

AAQUA commenced its extensive, by invitation only development program in late Q4 2020 and anticipates reaching general availability at the end of Q2 2021, with the first tangible partner, passion and icon activation initiatives commencing out of Asia shortly thereafter.

 

For further information:

All Active Asset Capital Limited

James Normand, Non-Executive Chairman

Rodger Sargent, Executive Director

www.aaacap.com 

 

Allenby Capital Limited (Nominated Adviser and Broker)

Alex Brearley / Nick Athanas

T: +44 (0) 203 328 5656

www.allenbycapital.com 

 

Buchanan (Financial PR)

Richard Oldworth / Chris Lane / Toto Berger

T: +44 (0) 207 466 5000

E: AAAC@buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRGPUPAPUPGGAP
Date   Source Headline
14th Jul 20208:05 amRNSStatement re Announcement by Asimilar
9th Jul 20201:10 pmRNSBoard Appointment
2nd Jul 20209:20 amRNSBlock admission application
30th Jun 20203:10 pmRNSStatement re Asimilar Interim Results
26th Jun 20201:22 pmRNSExtension of reporting deadline & portfolio update
22nd Jun 20204:35 pmRNSPrice Monitoring Extension
19th Jun 20202:41 pmRNSHolding(s) in Company
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:35 pmRNSPrice Monitoring Extension
17th Jun 202012:46 pmRNSHolding(s) in Company
16th Jun 20204:41 pmRNSSecond Price Monitoring Extn
16th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20209:30 amRNSAdmission of Placing Shares and Board Change
12th Jun 202011:30 amRNSResult of Extraordinary General Meeting
28th May 20207:00 amRNSBoard changes
22nd May 20208:41 amRNSNotice of Extraordinary General Meeting
14th May 20204:40 pmRNSSecond Price Monitoring Extn
14th May 20204:35 pmRNSPrice Monitoring Extension
14th May 20204:22 pmRNSRevised placing to raise £1.2 million
14th May 20202:06 pmRNSSecond Price Monitoring Extn
14th May 20202:01 pmRNSPrice Monitoring Extension
14th May 202012:19 pmRNSOptions over warrants in Asimilar Group plc
7th May 20205:42 pmRNSFurther re. proposed conditional placing
28th Apr 20207:00 amRNSUpdate on proposed placing to raise £1.26 million
17th Apr 20202:57 pmRNSHolding(s) in Company
17th Apr 20202:52 pmRNSHolding(s) in Company
17th Apr 20202:50 pmRNSHolding(s) in Company
16th Apr 202011:53 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSHolding(s) in Company
3rd Apr 20203:24 pmRNSProposed conditional placing
30th Mar 202012:10 pmRNSInvestment in shares in Asimilar Group Plc
26th Mar 20201:25 pmRNSHolding(s) in Company
20th Mar 20202:15 pmRNSInvestment in warrants in Asimilar Group Plc
10th Mar 202012:54 pmRNSChange of Board Roles
28th Feb 20205:00 pmRNSTotal Voting Rights
27th Feb 202012:58 pmRNSHolding(s) in Company
27th Feb 202012:58 pmRNSHolding(s) in Company
27th Feb 202011:13 amRNSHolding(s) in Company
24th Feb 202012:24 pmRNSResult of Extraordinary General Meeting
10th Feb 202011:01 amRNSAvailability of circular
5th Feb 20203:49 pmRNSProposed conditional placing to raise £200,000
31st Jan 202012:17 pmRNSBoard changes
15th Oct 20192:10 pmRNSChange of Name
10th Oct 201911:09 amRNSResult of Extraordinary General Meeting
30th Sep 20195:00 pmRNSTotal Voting Rights
24th Sep 20191:51 pmRNSInterim Results for the period ended 30 June 2019
23rd Sep 20191:00 pmRNSCompletion of placing and other matters
20th Sep 201911:04 amRNSAvailability of circular
17th Sep 201911:19 amRNSPlacing to raise £125,000 and other matters
30th Jul 20191:39 pmRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.